Colitis ulcerosa: vizsgálatok itt: Izrael
14 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Ashdod, Ashkelon, Haifa, Jerusalem, Kfar Saba, Tsrifin
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 2. fázisTaking peopleA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
- Életkor
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Jerusalem
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Ashdod, Haifa, Holon/Tel Aviv, Kefar Sava, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv, Yeruham
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Beersheba, Beer Yaaqov, Haifa, Jerusalem, Nahariya
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 2. fázisTaking peopleStudy of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Where
- Ashdod
- Életkor
- 18 év to 75 év
- People
- 2000 worldwide
- Run by
- AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00 - 2. fázisTaking peopleA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Haifa, Jerusalem, Ramat Gan, Rehovot, Tsrifin
- Életkor
- 2 év to 11 év
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00 - 2/3. fázisTaking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Haifa, Jerusalem, Petah Tikva
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Jerusalem, Tel Aviv
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 3. fázisTaking peopleA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva, Tsrifin
- Életkor
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606 - 4. fázisNot yet taking people in IzraelCombination CurQD and Vedolizumab in Ulcerative Colitis
- Where
- Ramat Gan
- Életkor
- 18 év to 80 év
- People
- 160 worldwide
- Run by
- Ryan C Ungaro
See details and how to joinNCT07665294 - No phaseTaking peopleIndividualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
- Where
- Tel Aviv
- Életkor
- 18 év and over
- People
- 40
- Run by
- Shmuel Kivity, MD
See details and how to joinNCT07644117 - 3. fázisTaking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva
- Életkor
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00